Mertiva AB, formerly Diamyd Medical AB, is a Sweden-based company active within the healthcare sector. As of August 31, 2013, the Company owned 8% shares of the United-States based Protein Sciences Corporation, as well as 19% shares of Mercodia AB. The Company changed its name in May 2013. Additionally, its subsidiary, Diamyd Therapeutics, was spun off and changed its name to Diamyd Medical.

Employees

Sector

Biotechnology & Medical Research

More about the company

28/08/17	Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	CI
11/08/17	Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	CI

Market Cap	772M 690M 637M 578M 1.08B 73.33B 1.1B 7.67B 3.04B 38.42B 2.9B 2.84B 121B	P/E 2018	28.3x	P/E 2019	13.3x
Enterprise Value	689M 616M 569M 515M 964M 65.45B 980M 6.84B 2.71B 34.29B 2.59B 2.53B 108B	EV / Sales 2018	-	EV / Sales 2019	-
Free-Float	68.13%	Yield 2018 *	-	Yield 2019	-

28/08/17	Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	CI
11/08/17	Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	CI
11/07/17	Sanofi Pasteur Inc. agreed to acquire Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others for $750 million	CI
29/11/15	Mertiva AB's Equity Buyback announced on December 6, 2012, has expired.	CI
18/12/14	Mertiva AB (OTCPK:DMYD.F) acquired an additional 0.54% stake in Protein Sciences Corporation for $0.62 million.	CI
22/01/14	Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	CI
11/10/13	Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	CI
08/10/13	The members of the management of Diamyd, Inc. cancelled the acquisition of 90% stake in Diamyd Inc. from Diamyd Medical AB (OM:DIAM B).	CI
25/09/13	Mertiva AB (OTCPK:DMYD.F) acquired an additional 7.27% stake in Protein Sciences Corporation from Pacific Rim Ventures Co., Ltd. and other shareholders for $8.4 million.	CI
27/08/13	Mertiva AB(NGM:MERT MTF) dropped from OMX Nordic All-Share Index	CI
30/07/13	Mertiva AB(NGM:MERT MTF) dropped from OMX Nordic Small Cap Index	CI
04/07/13	Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	CI
23/04/13	Diamyd Medical AB Announces Board Appointments	CI

Date	Insider	Type	Main position	Quantity	% Market Cap.
10/14/20 A	Sven Håkan Blomdahl	Buy	Chairman	24,314	0.1775%
10/8/20 A	Sven Håkan Blomdahl	Buy	Chairman	5,378	0.0393%
10/8/20 A	Sven Håkan Blomdahl	Buy	Chairman	821	0.0060%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MERTIVA AB	-	0.00%	-	-	89.46M
WUXI APPTEC CO., LTD.	+2.41%	+0.29%	+39.41%	+72.14%	64.69B
ARGENX SE	-0.15%	+7.50%	+11.42%	+71.27%	54.78B
LONZA GROUP AG	+0.57%	+4.60%	+7.71%	+90.93%	53.49B
IQVIA HOLDINGS INC.	+0.37%	+4.67%	+26.68%	+49.64%	45.98B
BEONE MEDICINES AG	-1.21%	+2.32%	+21.50%	+118.33%	42.94B
REVOLUTION MEDICINES, INC.	-0.37%	+5.07%	+243.23%	+789.58%	40.08B
CELLTRION, INC.	+0.05%	+0.21%	+18.06%	+48.50%	33.52B
WUXI BIOLOGICS (CAYMAN) INC.	+1.19%	-4.98%	+26.31%	-0.76%	23.97B
GENMAB A/S	-0.38%	+5.68%	+38.39%	+28.35%	23.67B
Average	+0.28%	+2.41%	+48.08%	+140.89%	38.32B
Weighted average by Cap.	+0.39%	+2.73%	+46.02%	+142.84%

Mertiva AB Stock

Stocks

MERT A

SE0010023432

Biotechnology & Medical Research

Valuation: Mertiva AB

Latest news: Mertiva AB

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

	2018	2019
Net sales	-	-
Net income	25.3M 22.59M 20.87M 18.91M 35.38M 2.4B 35.97M 251M 99.43M 1.26B 94.94M 92.93M 3.97B	76.99M 68.75M 63.52M 57.56M 108M 7.31B 109M 764M 303M 3.83B 289M 283M 12.07B
Net Debt	-253M -226M -209M -189M -354M -24B -360M -2.51B -994M -12.58B -949M -929M -39.65B	-83.08M -74.19M -68.54M -62.11M -116M -7.89B -118M -825M -327M -4.13B -312M -305M -13.03B

End-of-day quote NORDIC GROWTH MARKET
- ^SEK	-